Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the UBS MedTech, Tools and Genomics Summit on Tuesday, August 15^th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Celine Martin, Company Group Chairman Cardiovascular & Specialty Solutions Group (CSS), Anthony (Tony) Long, VP, Clinical Research, Medical Affairs, Preclinical Research and Jasmina Brooks, President Biosense Webster will represent the Company in a session scheduled at 2:00 pm (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230710327307/en/

Investor Contact:

investor-relations@its.jnj.com

Media Contact:

media-relations@its.jnj.com

Source: Johnson & Johnson